BIOCEPT, INC. Deferred Tax Assets, Valuation Allowance
BIOCEPT, INC. had Deferred Tax Assets, Valuation Allowance of $29.88 million as of 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2023-04-17
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $29.88M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $23.08M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $25.14M; Deferred Tax Assets, Valuation Allowance as first filed $25.14M.
- 2019-12-31: Deferred Tax Assets, Valuation Allowance $20.61M; Deferred Tax Assets, Valuation Allowance as first filed $20.61M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2022-12-31 | $29.88M 10-K · filed 2023-04-17 | |
| 2021-12-31 | $23.08M 10-K · filed 2023-04-17 | |
| 2020-12-31 | $25.14M 10-K · filed 2022-04-05 | $25.14M 10-K · filed 2021-03-31 |
| 2019-12-31 | $20.61M 10-K · filed 2021-03-31 | $20.61M 10-K · filed 2020-03-27 |
| 2018-12-31 | $15.12M 10-K · filed 2020-03-27 | |
| 2017-12-31 | $9.04M 10-K · filed 2019-03-29 | $8.69M 10-K · filed 2018-03-28 |
| 2016-12-31 | $6.90M 10-K · filed 2018-03-28 | |
| 2015-12-31 | $9.86M 10-K · filed 2017-03-28 | |
| 2014-12-31 | $53.99M 10-K · filed 2016-03-10 | |
| 2013-12-31 | $49.70M 10-K · filed 2015-03-11 |